Synfacts, Table of Contents

Synfacts 2022; 18(10): 1147
DOI: 10.1055/s-0041-1738705

Innovative Drug Discovery and Development

Synthesis of BLU-945, an EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

Contributor(s):

Antonia F. Stepan (Roche)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)